Rocket Pharmaceuticals, Inc. (NASDAQ:RCKTW – Get Free Report)’s stock price traded up 20% during mid-day trading on Thursday . The company traded as high as $0.12 and last traded at $0.12. 1,041 shares traded hands during trading, a decline of 95% from the average session volume of 20,179 shares. The stock had previously closed at $0.10.
Rocket Pharmaceuticals Stock Up 20.0 %
The firm’s fifty day simple moving average is $0.07 and its 200 day simple moving average is $0.12.
Rocket Pharmaceuticals Company Profile
Rocket Pharmaceuticals, Inc, together with its subsidiaries, operates as a multi-platform biotechnology company that focuses on developing gene therapies for rare and devastating diseases. It has three clinical-stage ex vivo lentiviral vector programs for fanconi anemia, a genetic defect in the bone marrow that reduces production of blood cells or promotes the production of faulty blood cells; leukocyte adhesion deficiency-I, a genetic disorder that causes the immune system to malfunction; and pyruvate kinase deficiency, a rare red blood cell autosomal recessive disorder that results in chronic non-spherocytic hemolytic anemia.
Featured Stories
- Five stocks we like better than Rocket Pharmaceuticals
- Should You Add These Warren Buffett Stocks to Your Portfolio?
- Edgewise Therapeutics Soars 50%: Key Reasons Behind the Surge
- Golden Cross Stocks: Pattern, Examples and Charts
- How the Fed’s Rate Cut Could Supercharge These 3 ETFs
- Which Wall Street Analysts are the Most Accurate?
- Microsoft Stock: 3 Reasons It’s Ready to Crush Q4
Receive News & Ratings for Rocket Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Rocket Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
